IL13RA2 and neoplasm: Sunitinib failed to suppress tumor growth of 786-O xenograft tumors when IL13RA2 was overexpressed, and sunitinib inhibited tumor growth of Caki-1 xenograft tumors knocked down for IL13RA2 in vivo.